Hantech Bio-Technology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	149.46	167.09	75.04
Cash & Short-Term Investments	158.61	167.09	75.04
Cash Growth	-	122.67%	-
Accounts Receivable	126.73	88.43	50.06
Other Receivables	0.05	0.21	0.01
Receivables	126.78	88.64	50.07
Inventory	103.71	80.47	29.32
Prepaid Expenses	2.6	3.72	4.24
Total Current Assets	391.7	339.91	158.68
Property, Plant & Equipment	553.44	551.32	285.23
Other Intangible Assets	2.46	3.25	1.47
Long-Term Deferred Tax Assets	1.82	1.81	2.27
Other Long-Term Assets	26.25	34.65	25.95
Total Assets	975.67	930.94	473.59
Accounts Payable	93.16	99.17	33.7
Accrued Expenses	51.88	49.75	25.29
Short-Term Debt	-	-	1
Current Portion of Long-Term Debt	31.86	23.18	5.94
Current Portion of Leases	6.69	6.63	6.57
Current Income Taxes Payable	23.6	30.01	8.91
Current Unearned Revenue	22.83	10.38	13.51
Other Current Liabilities	20.88	5.22	1.82
Total Current Liabilities	250.91	224.34	96.74
Long-Term Debt	243.67	285.1	84.48
Long-Term Leases	11.99	15.35	20.84
Long-Term Unearned Revenue	4.61	4.77	2.95
Long-Term Deferred Tax Liabilities	0.09	-	0.01
Total Liabilities	511.27	529.56	205.02
Common Stock	252.39	193.67	166.34
Additional Paid-In Capital	37.12	36.88	36.85
Retained Earnings	171.73	167.55	63.7
Total Common Equity	461.24	398.09	266.89
Minority Interest	3.17	3.29	1.68
Shareholders' Equity	464.4	401.38	268.57
Total Liabilities & Equity	975.67	930.94	473.59
Total Debt	294.21	330.27	118.83
Net Cash (Debt)	-135.6	-163.18	-43.79
Net Cash Per Share	-5.23	-6.36	-1.85
Filing Date Shares Outstanding	25.24	25.18	23.2
Total Common Shares Outstanding	25.24	25.18	23.2
Working Capital	140.8	115.57	61.94
Book Value Per Share	18.27	15.81	11.50
Tangible Book Value	458.78	394.84	265.42
Tangible Book Value Per Share	18.18	15.68	11.44
Land	214.44	214.44	87.04
Buildings	244.56	241.98	-
Machinery	126.93	113.95	87.08
Construction In Progress	9.78	9.78	125.77
Leasehold Improvements	7.43	7.4	7.36

Source: S&P Capital IQ. Standard template. Financial Sources.